AAAAAA

   
Results: 1-25 | 26-50 | 51-73
Results: 1-25/73

Authors: CHANZY B DUCBIN DL ROUSSET B MORAND P MORELBACCARD C MARCHETTI B FAUCONNIER J MALLARET MR ZARSKI JP SEIGNEURIN JM
Citation: B. Chanzy et al., EFFICIENCY OF A MANUAL DISINFECTION PROCEDURE TO ELIMINATE HEPATITIS-C (HCV) FROM EXPERIMENTALLY-CONTAMINATED DIGESTIVE ENDOSCOPES, Infection control and hospital epidemiology, 19(9), 1998, pp. 81-81

Authors: TRINCHET JC LEBREC D SCOAZEC JY BELGHITI J BLANC P GUYADER D LARREY D MALLAT A PARAF F PELLETIER G POL S MOREAU R VILGRAIN V ZARSKI JP
Citation: Jc. Trinchet et al., GASTROENTEROLOGIE-CLINIQUE-ET-BIOLOGIQUE - BILAN OF THE HEPATOLOGY SECTION, FROM 1995 TO 1997, Gastroenterologie clinique et biologique, 22(3), 1998, pp. 299-300

Authors: MOSNIER JF DETRAVERSAY C LEROY V SCOAZEC JY ZARSKI JP
Citation: Jf. Mosnier et al., VARIATIONS OF VASCULAR ADHESION MOLECULE EXPRESSION DURING CHRONIC HEPATITIS-C (CHC) TREATED WITH INTERFERON, Hepatology, 28(4), 1998, pp. 799-799

Authors: LEROY V BARNOUD R DETRAVERSAY C HARTMANN JD OUZAN D BAUD M MAYNARD M ZARSKI JP
Citation: V. Leroy et al., DO CHRONIC HEPATITIS-C (CHC) PATIENTS NON RESPONDER TO ALPHA-IFN IMPROVE HISTOLOGICAL LESIONS, Hepatology, 28(4), 1998, pp. 857-857

Authors: LEROY V MAYNARD M DETRAVERSAY C ROLACHON A BARNOUD R BAUD M HAMICI L FOURNET J ZARSKI JP
Citation: V. Leroy et al., ARE EPIDEMIOLOGIC CHARACTERISTICS OF CHRONIC HEPATITIS-C PATIENTS CHANGING - A PROSPECTIVE-STUDY ON 1068 PATIENTS, Hepatology, 28(4), 1998, pp. 1617-1617

Authors: NEGRO F SAMII K RUBBIABRANDT L QUADRI R ZARSKI JP BAUD M MALE PJ GIOSTRA E BERIS P HADENGUE A
Citation: F. Negro et al., HFE GENOTYPING IN CHRONIC HEPATITIS-C PATIENTS WITH AND WITHOUT LIVERSIDEROSIS, Hepatology, 28(4), 1998, pp. 2063-2063

Authors: ZARSKI JP MAYNARDMUET M CHOUSTERMAN S BAUD M BARNOUD R ABERGEL A BACQ Y COMBIS JM CAUSSE X TRAN A OBERTI F MINELLO A BRESSONHADNI S BAILLY F RAABE JJ LEROY V HAMICI L HICHAM T GIRARDIN MFS
Citation: Jp. Zarski et al., TENOXICAM, A NONSTEROID ANTIINFLAMMATORY DRUG, IS UNABLE TO INCREASE THE RESPONSE RATE IN PATIENTS WITH CHRONIC HEPATITIS-C TREATED BY ALPHA-INTERFERON, Hepatology, 27(3), 1998, pp. 862-867

Authors: LEROY V BAUD M DETRAVERSAY C MAYNARDMUET M LEBON P ZARSKI JP
Citation: V. Leroy et al., ROLE OF ANTIINTERFERON ANTIBODIES IN BREAKTHROUGH OCCURRENCE DURING ALPHA-2A AND ALPHA-2B THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C, Journal of hepatology, 28(3), 1998, pp. 375-381

Authors: ZARSKI JP BOHN B BASTIE A PAWLOTSKY JM BAUD M BOSTBEZEAUX F VANNHIEU JT SEIGNEURIN JM BUFFET C DHUMEAUX D
Citation: Jp. Zarski et al., CHARACTERISTICS OF PATIENTS WITH DUAL INFECTION BY HEPATITIS-B AND HEPATITIS-C VIRUSES, Journal of hepatology, 28(1), 1998, pp. 27-33

Authors: LEROY V ARVIEUX J JACOB MC MAYNARDMUET M BAUD M ZARSKI JP
Citation: V. Leroy et al., PREVALENCE AND SIGNIFICANCE OF ANTICARDIOLIPIN, ANTI-BETA(2) GLYCOPROTEIN-I AND ANTI-PROTHROMBIN ANTIBODIES IN CHRONIC HEPATITIS-C, British Journal of Haematology, 101(3), 1998, pp. 468-474

Authors: DHUMEAUX D DOFFOEL M BEDOSSA P BIGARD MA BISMUTH H CACOUB P CARPENTIER F COUROUCE AM DUROCHER A GALMICHE JP GOUDEAU A HILLON P MARCELLIN P OULDAOUDIA V PHAM BN RAGUIN G AUBREGE A ASSIE P CARO D CHAVANET P COLOMB M DUCROTTE P FRANCO D GORDIN J GOUILLOUD S HAMMEL JP HUGUET C PARIENTE A REVEL M RICHARD S SALAMON R WORONOFFLEMSI MC BRECHOT C BRISSOT P COUZIGOU P DEGOS F DESENCLOS JC DEUGNIER Y DURAND JM LARREY D LUNELFABIANI F MARCELLIN P MIGUET JM MOATTI JP PASCAL JP PAWLOTSKY JM POUPON R POYNARD T TREPO C ZARSKI JP MUSSET L PEREZ P TRAN A SERFATY L PAYEN JL OUZAN D
Citation: D. Dhumeaux et al., CONSENSUS CONFERENCE ON SCREENING AND TRE ATMENT OF HEPATITIS-C, La Presse medicale, 26(3), 1997, pp. 126-128

Authors: ZARSKI JP LEROY V
Citation: Jp. Zarski et V. Leroy, RISK-FACTORS IN THE TRANSMISSION OF HEPAT ITIS-C VIRUS, Gastroenterologie clinique et biologique, 21(1BIS), 1997, pp. 4-10

Authors: ROLACHON A KEZACHIAN G CAUSSE X BAUD M LEROY V MAYNARDMUET M PASQUIER D ZARSKI JP
Citation: A. Rolachon et al., EFFICACY OF ALPHA-INTERFERON IN CHRONIC H EPATITIS-C PATIENTS NON RESPONDER TO A FIRST TREATMENT - A PILOT PROSPECTIVE AND RANDOMIZED TRIAL, Gastroenterologie clinique et biologique, 21(12), 1997, pp. 924-928

Authors: THELU MA BAUD M LEROY V SEIGNEURIN JM ZARSKI JP
Citation: Ma. Thelu et al., EVOLUTION OF GENETIC-HETEROGENEITY OF THE HYPERVARIABLE REGION 1 IN PATIENTS WITH CHRONIC HEPATITIS-C NON RESPONDERS TO INTERFERON THERAPY, Hepatology, 26(4), 1997, pp. 328-328

Authors: ZARSKI JP MAYNARDMUET M CHOUSTERMAN S BAUD M BARNOUD R ABERGEL A BACQ Y COMBIS JM CAUSSE X TRAN A OBERTI F MINELLO A BRESSONHADNI S BAILLY F RAABE JJ HAMICI L HICHAM T GIRARDIN MFS
Citation: Jp. Zarski et al., NON STEROID ANTIINFLAMMATORY DRUGS ARE NOT ABLE TO INCREASE THE RESPONSE RATE IN PATIENTS WITH CHRONIC HEPATITIS-C TREATED BY INTERFERON-ALPHA - A RANDOMIZED CONTROLLED TRIAL, Hepatology, 26(4), 1997, pp. 358-358

Authors: DURAND M VINANTE N BAUD M ABERGEL A TRAN A ARVERS P SEIGNEURIN JM MICOUD M ZARSKI JP
Citation: M. Durand et al., VACCINATION AGAINST HEPATITIS-B VIRUS IN PATIENTS WITH CHRONIC HEPATITIS-C - EFFICACY, TOLERANCE AND RESPONSE PREDICTIVE FACTORS IN A CASE-CONTROL STUDY, Hepatology, 26(4), 1997, pp. 362-362

Authors: LEROY V BAUD M DETRAVERSAY C MAYNARDMUET M LEBON P ZARSKI JP
Citation: V. Leroy et al., ROLE OF NEUTRALIZING ANTI INTERFERON ANTIBODIES IN BREAKTHROUGH OCCURRENCE DURING ALPHA-2A AND ALPHA-2B THERAPY IN CHRONIC HEPATITIS-C PATIENTS, Hepatology, 26(4), 1997, pp. 705-705

Authors: CASTELNAU C ZARSKI JP POUPON R METREAU JM HACHEMANE S TREPO C COUZIGOU P TRAN A CAUSSE X BETTAN L GRANGER D CAPRON JP CALES P GAUTHIER A LEGER E DEPAILLETTE ED MARCELLIN P
Citation: C. Castelnau et al., RANDOMIZED CONTROLLED TRIAL OF POLYADENUR (POLYA POLYU) FOLLOWED BY ALPHA-INTERFERON VERSUS ALPHA-INTERFERON ALONE IN PATIENTS WITH CHRONICHEPATITIS-B, Hepatology, 26(4), 1997, pp. 1186-1186

Authors: JOUVINMARCHE E VIGAN J DELACHANAL E PERNOLLET M COLOMB M LEROY V ZARSKI JP MARCHE PN
Citation: E. Jouvinmarche et al., ANALYSIS OF T-CELL ANTIGEN RECEPTOR DIVERSITY IN INTRAHEPATIC T-LYMPHOCYTES OF CHRONIC HEPATITIS-C PATIENTS, Hepatology, 26(4), 1997, pp. 1619-1619

Authors: LEROY V ARVIEUX J JACOB MC MAYNARDMUET M BAUD M ZARSKI JP
Citation: V. Leroy et al., PREVALENCE AND SIGNIFICANCE OF ANTICARDIOLIPIN AND ANTIPHOSPHOLIPID COFACTORS ANTIBODIES IN CHRONIC HEPATITIS-C/, Hepatology, 26(4), 1997, pp. 1678-1678

Authors: ROUDOTTHORAVAL F BASTIE A PAWLOTSKY JM DHUMEAUX D AUDIGIER JC BARBARE JC BAUDET JG BEAUGRAND M BERTHELOT P BRECHOT C POL S CATTAN D BETTAN L CHAPUT JC COUZIGOU P DAO MT DENIS J DOFFOEL M DRUCKER J ERLINGER S MARCELLIN P ETIENNE JP BUFFET C LAURENTPUIG P FILOCHE B GAUCHER P GAUTHIER A DELREZ R INK O METMAN E BACQ Y MICHEL H LARREY D MIGUET JP BRESSONHADNI S MORICHAUBEAUCHANT M OPOLON P POYNARD T PASCAL JP PAYEN JL POUPON R SERFATY L SONDAG D TERRIS G TREPO C AHMED SNS WAGNER JC ZARSKI JP MAYNARD M
Citation: F. Roudotthoraval et al., EPIDEMIOLOGIC FACTORS AFFECTING THE SEVERITY OF HEPATITIS-C VIRUS-RELATED LIVER-DISEASE - A FRENCH SURVEY OF 6,664 PATIENTS, Hepatology, 26(2), 1997, pp. 485-490

Authors: GALMICHE JP AUBREGE A ASSIE P CARO D CHAVANET P COLOMB M DUCROTTE P FRANCO D GORDIN J GOUILLOUD S HAMMEL JP HUGUET C PARIENTE A REVEL M RICHARD S SALAMON R WORONOFFLEMSI MC BRECHOT C BRISSOT P COUZIGOU P DEGOS F DESENCLOS JC DEUGNIER Y DURAND JM LARREY D LUNELFABIANI F MARCELLIN P MIGUET JP MOATTI JP PASCAL JP PAWLOTSKY JM POUPON R POYNARD T TREPO C ZARSKI JP MUSSET L PEREZ P TRAN A SERFATY L PAYEN JL OUZAN D
Citation: Jp. Galmiche et al., HEPATITIS-C - SCREENING AND MANAGEMENT, La Semaine des hopitaux de Paris, 73(13-14), 1997, pp. 393-398

Authors: DURAND M BOST F MAYNARD M BAUD M COHARD M ZARSKI JP
Citation: M. Durand et al., VIDARABIN-INTERFERON COMBINATION IN PATIE NTS WITH A MUTANT FORM OF CHRONIC HEPATITIS-B - EFFICACY AND TOLERANCE IN A PILOT-STUDY, La Presse medicale, 25(9), 1996, pp. 459-459

Authors: PAWLOTSKY JM LUNEL F ZARSKI JP LAURENTPUIG P BRECHOT C
Citation: Jm. Pawlotsky et al., SEROLOGICAL AND MOLECULAR DIAGNOSIS OF HE PATITIS-C VIRUS-INFECTIONS, Gastroenterologie clinique et biologique, 20(2), 1996, pp. 146-161

Authors: POUPON RE HUET PM POUPON R BONNAND AM VANNHIEU JT ZAFRANI ES BRESSONHADNI S MIGUET JP MATHIEUCHANDELIER C DOFFOEL M VETTER D ZARSKI JP PARIENTE EA CAPRON JP GRANGE JD DAVID A DEGOS F BOUNIN M DHUMEAUX D ZAFRANI ES MYARA A GUECHOT J
Citation: Re. Poupon et al., A RANDOMIZED TRIAL COMPARING COLCHICINE AND URSODEOXYCHOLIC ACID COMBINATION TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS, Hepatology, 24(5), 1996, pp. 1098-1103
Risultati: 1-25 | 26-50 | 51-73